A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters - Concepedia

Concepedia

Publication | Open Access

A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

DOI Full Paper Access

37

Citations

29

References

2018

Year

Mao‐xu Ge, Weixiao Niu, Jinfeng Ren, Shi‐Ying Cai, Dongke Yu, Hongtao Liu, Na Zhang, Yixuan Zhang, Yucheng Wang, Rong‐Guang Shao,

Acta Pharmacologica Sinica

Metabolic SyndromeHepatologyLiver Disease DevelopmentMedicineLiver PhysiologyPathologyNovel Asbt InhibitorHepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolismPharmacologyLipid SynthesisHealth Sciences

References

	Year	Citations

Page 1

Page 1